147 related articles for article (PubMed ID: 12455885)
1. Subcellular localization of basic fibroblast growth factor and fibroblast growth factor receptor 1 in pituitary adenomas.
Fukui S; Otani N; Nawashiro H; Yano A; Nomura N; Miyazawa T; Ohnuki A; Tsuzuki N; Katoh H; Ishihara S; Shima K
Brain Tumor Pathol; 2002; 19(1):23-9. PubMed ID: 12455885
[TBL] [Abstract][Full Text] [Related]
2. Nuclear accumulation of basic fibroblast growth factor as a predictor for the recurrence of pituitary adenomas.
Fukui S; Otani N; Nawashiro H; Yano A; Miyazawa T; Ohnuki A; Tsuzuki N; Katoh H; Ishihara S; Suzuki T; Shima K
J Neurooncol; 2002 May; 57(3):221-9. PubMed ID: 12125985
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical study for basic fibroblast growth factor and fibroblast growth factor receptor I in pituitary adenomas.
Suzui H; Takahashi JA; Fukumoto M; Hashimoto N; Itoh N; Hatanaka M; Kikuchi H
Neurosci Lett; 1994 Apr; 171(1-2):192-6. PubMed ID: 7916136
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic expression of fibroblast growth factor receptor-4 in human pituitary adenomas: relation to tumor type, size, proliferation, and invasiveness.
Qian ZR; Sano T; Asa SL; Yamada S; Horiguchi H; Tashiro T; Li CC; Hirokawa M; Kovacs K; Ezzat S
J Clin Endocrinol Metab; 2004 Apr; 89(4):1904-11. PubMed ID: 15070963
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between basic fibroblast growth factor (bFGF) and cell proliferation, invasion in pituitary adenoma].
Wen L; Chen L; Liu YS
Hunan Yi Ke Da Xue Xue Bao; 2001 Oct; 26(5):466-8. PubMed ID: 12536505
[TBL] [Abstract][Full Text] [Related]
6. Ki-67 expression for predicting progression of postoperative residual pituitary adenomas: correlations with clinical variables.
Matsuyama J
Neurol Med Chir (Tokyo); 2012; 52(8):563-9. PubMed ID: 22976139
[TBL] [Abstract][Full Text] [Related]
7. Giant pituitary adenomas: pathologic-radiographic correlations and lack of role for p53 and MIB-1 labeling.
Madsen H; Borges TM; Knox AJ; Michaelis KA; Xu M; Lillehei KO; Wierman ME; Kleinschmidt-DeMasters BK
Am J Surg Pathol; 2011 Aug; 35(8):1204-13. PubMed ID: 21753697
[TBL] [Abstract][Full Text] [Related]
8. [Expression of pituitary tumor transforming gene, endostatin, and basic fibroblast growth factor mRNAs in invasive pituitary adenomas].
Chen L; Liu YS; Wang LS; Yin HG; Hou QT; Liu ZX; Chen LH; Ling F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):651-3, 666. PubMed ID: 16114549
[TBL] [Abstract][Full Text] [Related]
9. Recurrence in pituitary adenomas in childhood and adolescence.
Espay AJ; Azzarelli B; Williams LS; Bodensteiner JB
J Child Neurol; 2001 May; 16(5):364-7. PubMed ID: 11392522
[TBL] [Abstract][Full Text] [Related]
10. [The relationship between cell proliferation activity and secretory activity in pituitary adenoma--a review of 63 cases].
Asano K; Kubo O; Tajika Y; Huang MC; Takakura K
No To Shinkei; 1996 Jun; 48(6):543-9. PubMed ID: 8703557
[TBL] [Abstract][Full Text] [Related]
11. Minichromosome maintenance protein 7 as prognostic marker of tumor aggressiveness in pituitary adenoma patients.
Coli A; Asa SL; Fadda G; Scannone D; Chiloiro S; De Marinis L; Lauretti L; Ranelletti FO; Lauriola L
Eur J Endocrinol; 2016 Mar; 174(3):307-14. PubMed ID: 26620390
[TBL] [Abstract][Full Text] [Related]
12. P53 and MIB-1 immunohistochemistry as predictors of the clinical behavior of nonfunctioning pituitary adenomas.
Hentschel SJ; McCutcheon lE; Moore W; Durity FA
Can J Neurol Sci; 2003 Aug; 30(3):215-9. PubMed ID: 12945944
[TBL] [Abstract][Full Text] [Related]
13. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.
Saeger W; Lüdecke B; Lüdecke DK
Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):80-5. PubMed ID: 18072009
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of high molecular weight forms of basic fibroblast growth factor in human pituitary adenomas.
Li Y; Koga M; Kasayama S; Matsumoto K; Arita N; Hayakawa T; Sato B
J Clin Endocrinol Metab; 1992 Dec; 75(6):1436-41. PubMed ID: 1464644
[TBL] [Abstract][Full Text] [Related]
15. [Expression of basic fibroblast growth factor and its receptor in renal cell carcinoma].
Zhong H; Deng F; Kong X
Zhonghua Wai Ke Za Zhi; 1996 Nov; 34(11):651-4. PubMed ID: 9590749
[TBL] [Abstract][Full Text] [Related]
16. Nuclear accumulation of basic fibroblast growth factor in human astrocytic tumors.
Fukui S; Nawashiro H; Otani N; Ooigawa H; Nomura N; Yano A; Miyazawa T; Ohnuki A; Tsuzuki N; Katoh H; Ishihara S; Shima K
Cancer; 2003 Jun; 97(12):3061-7. PubMed ID: 12784342
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical localization of fibroblast growth factors (FGFs) and FGF receptor-1 in human normal salivary glands and pleomorphic adenomas.
Kusafuka K; Yamaguchi A; Kayano T; Takemura T
J Oral Pathol Med; 1998 Aug; 27(7):287-92. PubMed ID: 9725564
[TBL] [Abstract][Full Text] [Related]
18. Atypical pituitary adenomas: clinical characteristics and role of ki-67 and p53 in prognostic and therapeutic evaluation. A series of 50 patients.
Del Basso De Caro M; Solari D; Pagliuca F; Villa A; Guadagno E; Cavallo LM; Colao A; Pettinato G; Cappabianca P
Neurosurg Rev; 2017 Jan; 40(1):105-114. PubMed ID: 27215912
[TBL] [Abstract][Full Text] [Related]
19. p75 and TrkC neurotrophin receptors demonstrate a different immunoreactivity profile in comparison to TrkA and TrkB receptors in human normal pituitary gland and adenomas.
Assimakopoulou M; Zolota V; Chondrogianni C; Gatzounis G; Varakis J
Neuroendocrinology; 2008; 88(2):127-34. PubMed ID: 18319596
[TBL] [Abstract][Full Text] [Related]
20. Expression of basic fibroblast growth factor and its receptor-1 in cardiac myxoma.
Fujisawa H; Koide N; Kono T; Takayama K; Tsukioka K; Wada Y; Zhang T; Kitahara H; Nakano H; Suzuki JI; Isobe M; Amano J
J Cardiovasc Surg (Torino); 2002 Oct; 43(5):589-94. PubMed ID: 12386568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
